Controlled poly(L-lactide-co-trimethylene carbonate) delivery system of cyclosporine A and rapamycine - the effect of copolymer chain microstructure on drug release rate

被引:35
作者
Jelonek, Katarzyna [1 ]
Kasperczyk, Janusz [1 ,2 ]
Li, Suming [3 ]
Dobrzynski, Piotr [1 ,4 ]
Jarzabek, Bozena [1 ]
机构
[1] Polish Acad Sci, Ctr Polymer & Carbon Mat, PL-41819 Zabrze, Poland
[2] Med Univ Silesia, Dept Biopharm, Sch Pharm, PL-41200 Sosnowiec, Poland
[3] Univ Montpellier I, Inst Biomol Max Mousseron, CNRS, UMR 5247, F-34060 Montpellier, France
[4] Jan Dlugosz Univ Czestochowa, Inst Chem Environm Protect & Technol, PL-42218 Czestochowa, Poland
关键词
Cyclosporine A; Rapamycine; Biodegradable polymers; Microstructure; Controlled release; Poly(L-lactide-co-trimethylene carbonate); 1,3-TRIMETHYLENE CARBONATE; HYDROLYTIC DEGRADATION; EPSILON-CAPROLACTONE; IN-VITRO; LACTIDE; MICROSPHERES; SIROLIMUS; POLYMERS; ACID); CYA;
D O I
10.1016/j.ijpharm.2011.05.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of poly(L-lactide-co-TMC) chain microstructure (and its changes during degradation) on immunosuppressive drugs' release process was analyzed. Three kinds of poly(L-lactide-co-TMC) (PLATMC) - two semiblock and one random were used to prepare matrices containing cyclosporine A or rapamycine and drug free matrices. All of them degraded slowly enough to provide long term delivery of immunosuppressive agents. Moreover, copolymer chain microstructure determined the effect of drug loading on the degradation process. It was observed that matrices without drug obtained from semiblock copolymer degraded differently than matrices containing cyclosporine A or rapamycine, whereas all kinds of matrices obtained from random PLATMC degraded in similar way. This is the evidence that the only in case of semiblock copolymer factors concerning the presence of drug and the kind of drug influenced degradation process. Based on the obtained results, correlations between copolymer degradation and drug release process are proposed. According to our outcomes, regular drug release process may be obtained from highly randomized copolymers (R approximate to 1) that remain amorphous during degradation process. Determination of this factor may help in development of biodegradable systems, in which drug release rate and profile can be tailored by synthesis of polymer with appropriate chain microstructure. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 24 条
  • [1] In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices
    Alexis, F
    Venkatraman, SS
    Rath, SK
    Boey, F
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 98 (01) : 67 - 74
  • [2] Synthesis of biodegradable copolymers with low-toxicity zirconium compounds. V. Multiblock and random copolymers of L-lactide with trimethylene carbonate obtained in copolymerizations initiated with zirconium(IV) acetylacetonate
    Dobrzynski, P
    Kasperczyk, J
    [J]. JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 2006, 44 (10) : 3184 - 3201
  • [3] Controlled release from bioerodible polymers: effect of drug type and polymer composition
    Frank, A
    Rath, SK
    Venkatraman, SS
    [J]. JOURNAL OF CONTROLLED RELEASE, 2005, 102 (02) : 333 - 344
  • [4] Development and characterization of CyA-loaded poly(lactic acid)poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers
    Gref, R
    Quellec, P
    Sanchez, A
    Calvo, P
    Dellacherie, E
    Alonso, MJ
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2001, 51 (02) : 111 - 118
  • [5] HANG Z, 2004, J MATER SCI-MATER M, V15, P381
  • [6] Influence of Chain Microstructure on the Hydrolytic Degradation of Copolymers from 1,3-Trimethylene Carbonate and L-Lactide
    Hua, Jiajie
    Gebarowska, Katarzyna
    Dobrzynski, Piotr
    Kasperczyk, Janusz
    Wei, Jia
    Li, Suming
    [J]. JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 2009, 47 (15) : 3869 - 3879
  • [7] How should sirolimus be used in clinical practice?
    Johnson, RWG
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 79S - 83S
  • [8] The influence of copolymer chain microstructure on cyclosporine a (CyA) and Sirolimus prolonged and sustained release from PLA/TMC and PLA/PCL matrices
    Kasperczyk, J.
    Jelonek, K.
    Dobrzynski, P.
    Jarz, B.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 116 (02) : E5 - E6
  • [9] Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy
    Kasperczyk, J.
    Stoklosa, K.
    Dobrzynski, P.
    Stepien, K.
    Kaczmarczyk, B.
    Dzierzega-Lecznar, A.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 382 (1-2) : 124 - 129
  • [10] IMPLANTABLE SLOW-RELEASE CYCLOSPORINE A(CYA) DELIVERY SYSTEM TO THORACIC LYMPH DUCT
    KATAYAMA, N
    TANAKA, R
    OHNO, Y
    UEDA, C
    HOUJOU, T
    TAKADA, K
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 115 (01) : 87 - 93